References
- Abdel-Daim A, Ohura K, Imai T. (2018). A novel quantification method for serine hydrolases in cellular expression system using fluorophosphonate-biotin probe. Eur J Pharm Sci 114:267–74.
- Alexson SE, Diczfalusy M, Halldin M, Swedmark S. (2002). Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine. Drug Metab Dispos 30:643–7.
- Fernandez-Salguero P, Hoffman SM, Cholerton S, et al. (1995). A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 57:651–60.
- Gaedigk A, Jaime LK, Bertino JS, Jr, et al. (2010). Identification of novel CYP2D7-2D6 hybrids: non-functional and functional variants. Front Pharmacol 1:121.
- Gonzalez FJ. (1988). The molecular biology of cytochrome P450s. Pharmacol Rev 40:243–88.
- Holmes RS, Wright MW, Laulederkind SJ, et al. (2010). Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins. Mamm Genome 21:427–41.
- Hosokawa M. (1990). Differences in the functional roles of hepatic microsomal carboxylesterase isozymes in various mammals and humans. Drug Metab Dispos 5:953–63.
- Hosokawa M. (2008). Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules 13:412–31.
- Hosokawa M, Maki T, Satoh T. (1987). Multiplicity and regulation of hepatic microsomal carboxylesterases in rats. Mol Pharmacol 31:579–84.
- Hosokawa M, Maki T, Satoh T. (1990). Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. Arch Biochem Biophys 277:219–27.
- Igawa Y, Fujiwara S, Ohura K, et al. (2016). Differences in intestinal hydrolytic activities between cynomolgus monkeys and humans: evaluation of substrate specificities using recombinant carboxylesterase 2 isozymes. Mol Pharm 13:3176–86.
- Imai T. (2006). Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab Pharmacokinet 21:173–85.
- Imai T, Taketani M, Shii M, et al. (2006). Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab Dispos 34:1734–41.
- Kramer WE, Walker DL, O’Kane DJ, et al. (2009). CYP2D6: novel genomic structures and alleles. Pharmacogenet Genomics 19:813–22.
- Liu Y, Patricelli MP, Cravatt BF. (1999). Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci USA 96:14694–9.
- Nakanishi Y, Matsushita A, Matsuno K, et al. (2011). Regional distribution of drug-metabolizing enzyme activities in the liver and small intestine of cynomolgus monkeys. Drug Metab Pharmacokinet 26:288–94.
- Ohta T. (1989). Role of gene duplication in evolution. Genome 31:304–10.
- Speiser PW, White PC. (2003). Congenital adrenal hyperplasia. N Engl J Med 349:776–88.
- Taketani M, Shii M, Ohura K, et al. (2007). Carboxylesterase in the liver and small intestine of experimental animals and human. Life Sci 81:924–32.
- Uno Y, Fujino H, Kito G, et al. (2006). CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol Pharmacol 70:477–86.
- Uno Y, Matsushita A, Shukuya M, et al. (2014a). CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques. Biochem Pharmacol 91:242–8.
- Uno Y, Uehara S, Hosokawa M, Imai T. (2014b). Systematic identification and characterization of carboxylesterases in cynomolgus macaques. Drug Metab Dispos 42:2002–6.
- Uno Y, Uehara S, Kohara S, et al. (2015). CYP2D44 polymorphisms in cynomolgus and rhesus macaques. Mol Biol Rep 42:1149–55.
- Utoh M, Yoshikawa T, Hayashi Y, et al. (2015). Slow R-warfarin 7-hydroxylation mediated by P450 2C19 genetic variants in cynomolgus monkeys in vivo. Biochem Pharmacol 95:110–4.
- White PC, Speiser PW. (2000). Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–91.
- Williams ET, Bacon JA, Bender DM, et al. (2011). Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human. Drug Metab Dispos 39:2305–13.
- Williams ET, Wang H, Wrighton SA, et al. (2010). Genomic analysis of the carboxylesterases: identification and classification of novel forms. Mol Phylogenet Evol 57:23–34.
- Zhiyong F, Yanling S. (2002). Chinese primate status and primate captive breeding for biomedical research in China. In: Institute for Laboratory Animal Research, ed. International perspectives: the future of nonhuman primate resources. Washington (DC): National Academies Press, 36–45.